| abstract |
Use of a composition comprising one or more of: (i) an activated protein C (PCA), (ii) a functional fragment of a PCA, and (iii) protein C, as an active agent in the preparation of a topical medication to promote wound healing in a patient, wherein said wound is chosen from the group consisting of dermal ulcers, burns, oral wounds, bone and cartilage injury, and chemical-related skin necrosis. |